Biologicals in gastroenterology: TNF-blockers

被引：1
|
作者：
Scharl, M. [1 ]
Rogler, G. [1 ]
机构：
[1] Univ Spital Zurich, Dept Innere Med, Klin Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2010年 / 135卷 / 45期
关键词：
inflammatory bowel disease; Crohn's disease; ulcerative colitis; TNF-blocker; biologicals; CROHNS-DISEASE; INFLIXIMAB MAINTENANCE; EPISODIC TREATMENT; ADALIMUMAB; THERAPY; EFFICACY; SAFETY; INFECTIONS; ANTIBODY;
D O I：
10.1055/s-0030-1267508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TNF-blockers represent a well accepted therapeutic option in the treatment of inflammatory bowel disease. Though they are successfully used in many patients, they can also exert severe side effects, such as infectious diseases. Therefore, a careful review of the patient history as well as a continuous evaluation of the patients state of health is crucial before starting an anti-TNF therapy during the therapeutic treatment. In addition, we review also the possibilities by loss of efficacy of an anti-TNF therapy, such as dose increase or re-induction therapy. © 2010 Georg Thieme Verlag KG Stuttgart · New York.
引用
下载
收藏
页码：2243 / 2252
页数：10
相关论文
共 50 条
  • [31] Rheumatoid arthritis: Eligibility criteria for TNF-blockers therapy in the hospital setting; A multivariate analysis. (The precept study)
    Meyer, O
    Sany, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 465 - 465
  • [32] No Clinically Relevant Changes in Coagulation Activation Between Patients Initiating TNF-blockers versus JAK-inhibitors
    Hansildaar, Romy
    Raadsen, Reinder
    Heslinga, Maaike
    Nurmohamed, Michael
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 812 - 814
  • [33] Leflunomide in combination with TNF-blockers for Methotrexate intolerance [Leflunomid als Kombinationspartner von TNF-Blockern bei Methotrexat-Unverträglichkeit]
    Krüger K.
    Manger B.
    Zeitschrift für Rheumatologie, 2009, 68 (2) : 165 - 168
  • [34] The impact of therapy with TNF-blockers on health-related quality of life in rheumatoid arthritis patients. A pilot study
    Abalos Medina, Gracia Maria
    Ruiz Villaverde, Gonzalo
    Sanchez Cano, Daniel
    Ruiz Villaverde, Ricardo
    Ramirez Rodrigo, Jesus
    Raya Alvarez, Enrique
    Villaverde Gutierrez, Carmen
    REUMATOLOGIA CLINICA, 2011, 7 (03): : 167 - 171
  • [35] CORRELATION BETWEEN TNF-BLOCKERS BIOAVAILABILITY AND FCGRIIA H131R POLYMORPHISM IN TUNISIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mahmoud, Ines
    Moalla, Myriam
    Sfar, Imen
    Saidane, Olfa
    Ben Tekaya, Aicha
    Tekaya, Rawdha
    Hamdi, Wafa
    Aouini, Saloua
    Kchir, Mohamed Montacer
    Gorgi, Yousr
    Abdelmoula, Leila
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1656 - 1656
  • [36] Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy
    Freund, Romain
    Granger, Benjamin
    Francois, Cecile
    Carcelain, Guislaine
    Ravaud, Philippe
    Mariette, Xavier
    Fautrel, Bruno
    PRESSE MEDICALE, 2018, 47 (02): : E9 - E13
  • [37] THE RESPONSE TO TNF-BLOCKERS TREATMENT OF SpA PATIENTS IS INFLUENCED BY THE INTERPLAY BETWEEN HLA-B27 AND GUT MICROBIOTA COMPOSITION AT BASELINE
    Vallier, M.
    Dougados, M.
    Ferreira, S.
    Menegatti, S.
    Bianchi, E.
    Rogge, L.
    Chamaillard, M.
    Miceli-Richard, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 752 - 752
  • [38] The Response to TNF-Blockers Treatment of Spa Patients Is Influenced By the Interplay between HLA-B27 and Gut Microbiota Composition at Baseline
    Vallier, Marie
    Dougados, Maxime
    Ferreira, Stephanie
    Menegatti, Silvia
    Bianchi, Elisabetta
    Rogge, Lars
    Chamaillard, Mathias
    Miceli-Richard, Corinne
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [39] THE RESPONSE TO TNF-BLOCKERS TREATMENT OF SPA PATIENTS IS INFLUENCED BY THE INTERPLAY BETWEEN HLA-B27 AND GUT MICROBIOTA COMPOSITION AT BASELINE
    Vallier, M.
    Chamaillard, M.
    Ferreira, S.
    Menegatti, S.
    Bianchi, E.
    Rogge, L.
    Dougados, M.
    Miceli-Richard, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 996 - 996
  • [40] Retention Rate of TNF-blockers is Greater in Case of Advanced Spinal Ankylosis in Axial Spondyloarthritis: Data from the HUR-BIO Registry
    Kalyoncu, Umut
    Kilic, Levent
    Karadag, Omer
    Erden, Abdulsamet
    Bilgen, Sule Apras
    Akdogan, Ali
    Kiraz, Sedat
    Ertenli, Ihsan
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S66 - S66
12345